Tag: Peter LoDuca

Browse our exclusive articles!

Lawyers confess to fabricating cases with ChatGPT, beg court for mercy

Two lawyers are appearing before a US District Judge to defend their use of an AI chatbot to generate false cases for a lawsuit. They claim it was a good faith workaround as Westlaw and LexisNexis were unavailable. The product in question was OpenAI's ChatGPT, causing some amusement. It is uncertain if one lawyer will be punished for the chatbot's production of extended excerpts and fake case quotations.

Lawyers in Trouble for Faking Opinions on ChatGPT

Lawyers under fire for faking opinions and citing non-existent cases in a lawsuit against Avianca Airlines. In-person hearing set for June 9.

Lawyer Revealed to Cite Fabricated Cases Following ChatGPT Research

US lawyer faces penalties for citing fake cases in court after relying on ChatGPT for legal research and failing to understand its limitations.

Possible article title: Lawyer’s Reliance on ChatGPT to Write Brief: Risky Move? A lawyer entrusting ChatGPT for brief writing: Are there any red flags?

A lawyer's reliance on artificial intelligence software ChatGPT proved problematic, with fake court cases and quotes in the legal brief. This case highlights the need for validating AI outputs. The affected legal firm now stresses this point in its AI training, and the case has become a topic of conversation in the legal world. The lawyer involved threw himself on the mercy of the court, stating that he did not know the content could be fake.

AI Helps US Attorney with Case Research: Acknowledgment from Lawyer

Two lawyers face a court hearing for using ChatGPT, an AI-based tool, in legal research. Peter LoDuca and Steven A Schwartz's firm reportedly used the tool, unaware of its inaccuracies. Levidow, Levidow & Oberman, the company behind ChatGPT, provides the best legal advice and representation. Verify accuracy of AI tools to ensure reliable representation.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img